Skip to main content
. 2020 Nov 12;10:588862. doi: 10.3389/fonc.2020.588862

Figure 5.

Figure 5

Overall Survival according to administration of bone resorption inhibitors. Kaplan-Meier estimates of overall survival of EGFR-mutated lung cancer patients after diagnosis of bone metastases according to the administration of bisphosphonates/denosumab (EGFR, epidermal growth factor receptor).